The Common H202D Variant in GDF-15 Does Not Affect Its Bioactivity but Can Significantly Interfere with Measurement of Its Circulating Levels.

Saved in:
Bibliographic Details
Title: The Common H202D Variant in GDF-15 Does Not Affect Its Bioactivity but Can Significantly Interfere with Measurement of Its Circulating Levels.
Authors: Karusheva Y; MRC Metabolic Diseases Unit, Wellcome-MRC Institute of Metabolic Science, University of Cambridge, Cambridge, UK.; Department of Clinical Biochemistry, NIHR Cambridge Biomedical Research Centre, Cambridge, UK., Ratcliff M; Biologics Engineering, R&D, AstraZeneca, Cambridge, UK.; Department of Biochemistry, University of Cambridge, 80 Tennis Court Road, Cambridge CB2 1GA, UK., Mörseburg A; MRC Metabolic Diseases Unit, Wellcome-MRC Institute of Metabolic Science, University of Cambridge, Cambridge, UK.; Department of Clinical Biochemistry, NIHR Cambridge Biomedical Research Centre, Cambridge, UK., Barker P; Department of Clinical Biochemistry, NIHR Cambridge Biomedical Research Centre, Cambridge, UK.; Core Biochemical Assay Laboratory, Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 0QQ, UK., Melvin A; MRC Metabolic Diseases Unit, Wellcome-MRC Institute of Metabolic Science, University of Cambridge, Cambridge, UK.; Department of Clinical Biochemistry, NIHR Cambridge Biomedical Research Centre, Cambridge, UK., Sattar N; British Heart Foundation Glasgow Cardiovascular Research Centre, Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow G12 8TA, UK., Burling K; Department of Clinical Biochemistry, NIHR Cambridge Biomedical Research Centre, Cambridge, UK.; Department of Biochemistry, University of Cambridge, 80 Tennis Court Road, Cambridge CB2 1GA, UK., Backmark A; Discovery Biology, Discovery Sciences, Biopharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden., Roth R; Discovery Biology, Discovery Sciences, Biopharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden., Jermutus L; Projects, Research and Early Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK., Guiu-Jurado E; Department for Clinical Obesity Research, Helmholtz Institute for Metabolic, Obesity and Vascular Research (HI-MAG) of the Helmholtz Zentrum München at the University of Leipzig and University Hospital Leipzig, Leipzig, Germany., Blüher M; Department for Clinical Obesity Research, Helmholtz Institute for Metabolic, Obesity and Vascular Research (HI-MAG) of the Helmholtz Zentrum München at the University of Leipzig and University Hospital Leipzig, Leipzig, Germany., Welsh P; British Heart Foundation Glasgow Cardiovascular Research Centre, Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow G12 8TA, UK., Hyvönen M; Biologics Engineering, R&D, AstraZeneca, Cambridge, UK., O'Rahilly S; MRC Metabolic Diseases Unit, Wellcome-MRC Institute of Metabolic Science, University of Cambridge, Cambridge, UK.; Department of Clinical Biochemistry, NIHR Cambridge Biomedical Research Centre, Cambridge, UK.
Source: The journal of applied laboratory medicine [J Appl Lab Med] 2022 Oct 29; Vol. 7 (6), pp. 1388-1400.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 101693884 Publication Model: Print Cited Medium: Print ISSN: 2576-9456 (Print) Linking ISSN: 24757241 NLM ISO Abbreviation: J Appl Lab Med Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 35796717
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: The Common H202D Variant in GDF-15 Does Not Affect Its Bioactivity but Can Significantly Interfere with Measurement of Its Circulating Levels.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Karusheva+Y%22">Karusheva Y</searchLink>; MRC Metabolic Diseases Unit, Wellcome-MRC Institute of Metabolic Science, University of Cambridge, Cambridge, UK.; Department of Clinical Biochemistry, NIHR Cambridge Biomedical Research Centre, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Ratcliff+M%22">Ratcliff M</searchLink>; Biologics Engineering, R&D, AstraZeneca, Cambridge, UK.; Department of Biochemistry, University of Cambridge, 80 Tennis Court Road, Cambridge CB2 1GA, UK.<br /><searchLink fieldCode="AU" term="%22Mörseburg+A%22">Mörseburg A</searchLink>; MRC Metabolic Diseases Unit, Wellcome-MRC Institute of Metabolic Science, University of Cambridge, Cambridge, UK.; Department of Clinical Biochemistry, NIHR Cambridge Biomedical Research Centre, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Barker+P%22">Barker P</searchLink>; Department of Clinical Biochemistry, NIHR Cambridge Biomedical Research Centre, Cambridge, UK.; Core Biochemical Assay Laboratory, Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 0QQ, UK.<br /><searchLink fieldCode="AU" term="%22Melvin+A%22">Melvin A</searchLink>; MRC Metabolic Diseases Unit, Wellcome-MRC Institute of Metabolic Science, University of Cambridge, Cambridge, UK.; Department of Clinical Biochemistry, NIHR Cambridge Biomedical Research Centre, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Sattar+N%22">Sattar N</searchLink>; British Heart Foundation Glasgow Cardiovascular Research Centre, Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow G12 8TA, UK.<br /><searchLink fieldCode="AU" term="%22Burling+K%22">Burling K</searchLink>; Department of Clinical Biochemistry, NIHR Cambridge Biomedical Research Centre, Cambridge, UK.; Department of Biochemistry, University of Cambridge, 80 Tennis Court Road, Cambridge CB2 1GA, UK.<br /><searchLink fieldCode="AU" term="%22Backmark+A%22">Backmark A</searchLink>; Discovery Biology, Discovery Sciences, Biopharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.<br /><searchLink fieldCode="AU" term="%22Roth+R%22">Roth R</searchLink>; Discovery Biology, Discovery Sciences, Biopharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.<br /><searchLink fieldCode="AU" term="%22Jermutus+L%22">Jermutus L</searchLink>; Projects, Research and Early Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Guiu-Jurado+E%22">Guiu-Jurado E</searchLink>; Department for Clinical Obesity Research, Helmholtz Institute for Metabolic, Obesity and Vascular Research (HI-MAG) of the Helmholtz Zentrum München at the University of Leipzig and University Hospital Leipzig, Leipzig, Germany.<br /><searchLink fieldCode="AU" term="%22Blüher+M%22">Blüher M</searchLink>; Department for Clinical Obesity Research, Helmholtz Institute for Metabolic, Obesity and Vascular Research (HI-MAG) of the Helmholtz Zentrum München at the University of Leipzig and University Hospital Leipzig, Leipzig, Germany.<br /><searchLink fieldCode="AU" term="%22Welsh+P%22">Welsh P</searchLink>; British Heart Foundation Glasgow Cardiovascular Research Centre, Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow G12 8TA, UK.<br /><searchLink fieldCode="AU" term="%22Hyvönen+M%22">Hyvönen M</searchLink>; Biologics Engineering, R&D, AstraZeneca, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22O'Rahilly+S%22">O'Rahilly S</searchLink>; MRC Metabolic Diseases Unit, Wellcome-MRC Institute of Metabolic Science, University of Cambridge, Cambridge, UK.; Department of Clinical Biochemistry, NIHR Cambridge Biomedical Research Centre, Cambridge, UK.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101693884%22">The journal of applied laboratory medicine</searchLink> [J Appl Lab Med] 2022 Oct 29; Vol. 7 (6), pp. 1388-1400.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Oxford+University+Press%22">Oxford University Press </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101693884 <i>Publication Model: </i>Print <i>Cited Medium: </i>Print <i>ISSN: </i>2576-9456 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2224757241%22">24757241 </searchLink><i>NLM ISO Abbreviation: </i>J Appl Lab Med <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=35796717
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1093/jalm/jfac055
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1388
    Titles:
      – TitleFull: The Common H202D Variant in GDF-15 Does Not Affect Its Bioactivity but Can Significantly Interfere with Measurement of Its Circulating Levels.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Karusheva Y
      – PersonEntity:
          Name:
            NameFull: Ratcliff M
      – PersonEntity:
          Name:
            NameFull: Mörseburg A
      – PersonEntity:
          Name:
            NameFull: Barker P
      – PersonEntity:
          Name:
            NameFull: Melvin A
      – PersonEntity:
          Name:
            NameFull: Sattar N
      – PersonEntity:
          Name:
            NameFull: Burling K
      – PersonEntity:
          Name:
            NameFull: Backmark A
      – PersonEntity:
          Name:
            NameFull: Roth R
      – PersonEntity:
          Name:
            NameFull: Jermutus L
      – PersonEntity:
          Name:
            NameFull: Guiu-Jurado E
      – PersonEntity:
          Name:
            NameFull: Blüher M
      – PersonEntity:
          Name:
            NameFull: Welsh P
      – PersonEntity:
          Name:
            NameFull: Hyvönen M
      – PersonEntity:
          Name:
            NameFull: O'Rahilly S
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 29
              M: 10
              Text: 2022 Oct 29
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-print
              Value: 2576-9456
          Numbering:
            – Type: volume
              Value: 7
            – Type: issue
              Value: 6
          Titles:
            – TitleFull: The journal of applied laboratory medicine
              Type: main
ResultId 1